David Bench - 14 Jun 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZB)

Role
Chief Financial Officer
Signature
/s/ David Bench
Issuer symbol
ENZB
Transactions as of
14 Jun 2022
Net transactions value
+$7,525
Form type
4
Filing time
15 Jun 2022, 16:31:04 UTC
Previous filing
14 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENZ Common Stock, $0.01 Par Value Purchase $7,525 +3,500 +140% $2.15 6,000 14 Jun 2022 By Trust (PSP) F1
holding ENZ Common Stock, $0.01 Par Value 4,138 14 Jun 2022 401k F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENZ Stock Option (to acquire Common Stock) 87,500 14 Jun 2022 Common Stock 87,500 $2.98 Direct F3
holding ENZ Stock Option (to acquire Common Stock) 87,500 14 Jun 2022 Common Stock 87,500 $3.36 Direct F3
holding ENZ Stock Option (to acquire Common Stock) 55,400 14 Jun 2022 Common Stock 55,400 $2.63 Direct F3
holding ENZ Stock Option (to acquire Common Stock) 55,400 14 Jun 2022 Common Stock 55,400 $2.20 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held by David Bench Consulty Group, a profit sharing plan of which the reporting person is a participant.
F2 Represents restricted shares granted subject the Company's discretionary matching contribution and non-elective employer contribution which vest ratable over four years of service, which began on December 23, 2019.
F3 The stock options have a five-year term and will vest in three equal instalments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.